Ensysce Biosciences (ENSC) Stock: Buy, Sell, or Hold?
ENSC - Ensysce Biosciences, Inc. Common Stock
$0.41
-0.02 (-4.45%)
▼
5d:
+2.63%
30d:
-13.51%
90d:
+52.02%
HOLD
LOW Confidence
Analysis Updated: Oct 7, 2026 12:00 AM ET
Earnings: Nov 13, 2026
Get Alerted When ENSC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ENSC shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: ENSC shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: ENSC is currently trading at $0.41, which is considered fair relative to its 30-day fair value range of $0.40 to $0.47.
Technical Outlook: Technically, ENSC is in a strong uptrend. Immediate support is located at $0.39, while resistance sits at $0.44. Short-term momentum is weak, with the stock down 4.4% recently.
Market Sentiment: ENSC scores 69/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $8.25 (+1821.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ENSC is in a strong uptrend. Immediate support is located at $0.39, while resistance sits at $0.44. Short-term momentum is weak, with the stock down 4.4% recently.
Market Sentiment: ENSC scores 69/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $8.25 (+1821.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$0.40 -
$0.47
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
81.6%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (69/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.4%)
- BULLISH: Trading 1821.3% below Wall St target ($8.25)
- CAUTION: Bottoming setup, but lagging the sector by 30% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$0.40 -
$0.47
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$0.39
Resistance Level
$0.44
Current Trend
Strong Uptrend
Technical data as of
Oct 7, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-8.59
Wall Street Target
$8.25
(+1821.3%)
Revenue Growth (YoY)
-15.1%
Profit Margin
-280.5%
Share & Embed Analysis
Last updated: October 08, 2026 12:29 PM ET
Data refreshes hourly during market hours. Next update: 1:29 PM
Data refreshes hourly during market hours. Next update: 1:29 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ENSC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
REGN
Regeneron Pharmaceutical… |
BUY
27 analysts |
$853 | 60 BUY |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
22 analysts |
$294 | 47 HOLD |
|
DYN
Dyne Therapeutics Inc |
STRONG BUY
17 analysts |
$36 | 59 HOLD |
|
CGEM
Cullinan Oncology LLC |
STRONG BUY
12 analysts |
$33 | 68 BUY |
|
ACAD
ACADIA Pharmaceuticals I… |
STRONG BUY
20 analysts |
$32 | 52 HOLD |
